Daniel P. Chin

5.7k total citations · 2 hit papers
45 papers, 3.5k citations indexed

About

Daniel P. Chin is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Daniel P. Chin has authored 45 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 29 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Daniel P. Chin's work include Tuberculosis Research and Epidemiology (30 papers), Mycobacterium research and diagnosis (11 papers) and Pneumonia and Respiratory Infections (9 papers). Daniel P. Chin is often cited by papers focused on Tuberculosis Research and Epidemiology (30 papers), Mycobacterium research and diagnosis (11 papers) and Pneumonia and Respiratory Infections (9 papers). Daniel P. Chin collaborates with scholars based in United States, China and Switzerland. Daniel P. Chin's co-authors include Longde Wang, Lixia Wang, Yanlin Zhao, Jianjun Liu, Shengfen Wang, Guangxue He, Yu Wang, Christy Hanson, Yu Wang and Shuigao Jin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Daniel P. Chin

45 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

National Survey of Drug-Resistant Tuberculosis in China

2012 491 citations Yanlin Zhao, Lixia Wang et al. profile →
Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data

2014 407 citations Lixia Wang, Hui Zhang et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel P. Chin United States	29	2.4k	1.8k	757	348	322	45	3.5k
Rein M G J Houben United Kingdom	32	3.8k 1.6×	2.6k 1.5×	1.4k 1.8×	252 0.7×	138 0.4×	114	4.9k
Luís E. Cuevas United Kingdom	44	5.1k 2.2×	3.5k 1.9×	1.4k 1.8×	307 0.9×	129 0.4×	248	7.6k
Susan van den Hof Netherlands	35	2.3k 1.0×	2.1k 1.2×	841 1.1×	112 0.3×	303 0.9×	127	3.9k
Alison D. Grant United Kingdom	47	5.7k 2.4×	4.0k 2.2×	1.2k 1.6×	515 1.5×	77 0.2×	218	7.4k
Marieke J. van der Werf Netherlands	34	2.9k 1.2×	2.2k 1.2×	1.3k 1.7×	567 1.6×	40 0.1×	113	4.3k
Joan A. Caylà Spain	38	3.6k 1.5×	3.2k 1.7×	1.1k 1.5×	136 0.4×	86 0.3×	321	5.5k
J. Anthony G. Scott United Kingdom	47	1.2k 0.5×	4.2k 2.3×	295 0.4×	763 2.2×	176 0.5×	160	7.5k
Ethel Leonor Nóia Maciel Brazil	30	2.2k 0.9×	1.4k 0.8×	631 0.8×	282 0.8×	82 0.3×	224	3.5k
Badara Samb Senegal	31	1.5k 0.6×	1.3k 0.7×	161 0.2×	585 1.7×	108 0.3×	65	3.8k
Gregory Hussey South Africa	43	4.5k 1.9×	3.5k 1.9×	1.2k 1.6×	414 1.2×	97 0.3×	168	7.4k

Countries citing papers authored by Daniel P. Chin

Since Specialization

Citations

This map shows the geographic impact of Daniel P. Chin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Chin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Chin more than expected).

Fields of papers citing papers by Daniel P. Chin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Chin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Chin. The network helps show where Daniel P. Chin may publish in the future.

Co-authorship network of co-authors of Daniel P. Chin

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Chin. A scholar is included among the top collaborators of Daniel P. Chin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Chin. Daniel P. Chin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arinaminpathy, Nimalan, Gabriela B. Gomez, Kuldeep Singh Sachdeva, et al.. (2020). The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis. PLoS ONE. 15(3). e0230808–e0230808. 7 indexed citations

Huang, Fei, Hui Chen, Ni Wang, et al.. (2020). The impact of the COVID-19 epidemic on tuberculosis control in China. The Lancet Regional Health - Western Pacific. 3. 100032–100032. 69 indexed citations

Stagg, Helen R., James Lewis, Xiaoqiu Liu, et al.. (2019). Temporal Factors and Missed Doses of Tuberculosis Treatment. A Causal Associations Approach to Analyses of Digital Adherence Data. Annals of the American Thoracic Society. 17(4). 438–449. 20 indexed citations

Ou, Xichao, Shengfen Wang, Haiyan Dong, et al.. (2016). Multicenter evaluation of a real-time loop-mediated isothermal amplification (RealAmp) test for rapid diagnosis of Mycobacterium tuberculosis. Journal of Microbiological Methods. 129. 39–43. 11 indexed citations

Li, Renzhong, Yunzhou Ruan, Qiang Sun, et al.. (2015). Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: a before-and-after study. The Lancet Global Health. 3(4). e217–e228. 37 indexed citations

Ou, Xichao, Hui Xia, Qiang Li, et al.. (2014). A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China. International Journal of Infectious Diseases. 31. 41–46. 20 indexed citations

Wang, Lixia, Hui Zhang, Yunzhou Ruan, et al.. (2014). Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. The Lancet. 383(9934). 2057–2064. 407 indexed citations breakdown →

Ou, Xichao, Qiang Li, Hui Xia, et al.. (2014). Diagnostic Accuracy of the PURE-LAMP Test for Pulmonary Tuberculosis at the County-Level Laboratory in China. PLoS ONE. 9(5). e94544–e94544. 50 indexed citations

Cheng, Shiming, et al.. (2007). A new disease reporting system increases TB case detection in China. Europe PMC (PubMed Central). 8 indexed citations

10.

Wang, Longde, Jianjun Liu, & Daniel P. Chin. (2007). Progress in tuberculosis control and the evolving public-health system in China. The Lancet. 369(9562). 691–696. 187 indexed citations

11.

Cegielski, J. Peter, Daniel P. Chin, Marcos Espinal, et al.. (2002). The global tuberculosis situation: Progress and problems in the 20th century, prospects for the 21st century. Infectious Disease Clinics of North America. 16(1). 1–58. 89 indexed citations

12.

Turner, Joan G., et al.. (2001). Adverse Impact of Cigarette Smoking on Dimensions of Health-Related Quality of Life in Persons with HIV Infection. AIDS Patient Care and STDs. 15(12). 615–624. 84 indexed citations

13.

Jasmer, Robert M., David C. Snyder, Daniel P. Chin, et al.. (2000). Twelve Months of Isoniazid Compared with Four Months of Isoniazid and Rifampin for Persons with Radiographic Evidence of Previous Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 162(5). 1648–1652. 35 indexed citations

14.

Chin, Daniel P.. (2000). Spread of <EMPH TYPE="ITAL">Mycobacterium tuberculosis</EMPH> in a Community Implementing Recommended Elements of Tuberculosis Control. JAMA. 283(22). 2968–2968. 68 indexed citations

15.

Snyder, David C. & Daniel P. Chin. (1999). Cost-effectiveness Analysis of Directly Observed Therapy for Patients with Tuberculosis at Low Risk for Treatment Default. American Journal of Respiratory and Critical Care Medicine. 160(2). 582–586. 26 indexed citations

16.

Snyder, David C., et al.. (1999). Tuberculosis Prevention in Methadone Maintenance Clinics: Effectiveness and Cost-Effectiveness. American Journal of Respiratory and Critical Care Medicine. 160(1). 178–185. 37 indexed citations

17.

Chin, Daniel P., Kathryn DeRiemer, Peter M. Small, et al.. (1998). Differences in Contributing Factors to Tuberculosis Incidence in U.S.-born and Foreign-born Persons. American Journal of Respiratory and Critical Care Medicine. 158(6). 1797–1803. 103 indexed citations

18.

Mohle‐Boetani, Janet C., et al.. (1998). Movement of Tuberculosis Patients and the Failure to Complete Antituberculosis Treatment. American Journal of Respiratory and Critical Care Medicine. 157(4). 1249–1252. 45 indexed citations

19.

DeRiemer, Kathryn, Daniel P. Chin, Gisela Schecter, & Arthur Reingold. (1998). Tuberculosis Among Immigrants and Refugees. Archives of Internal Medicine. 158(7). 753–753. 55 indexed citations

20.

Schnapp, Lynn M., Daniel P. Chin, Nancy L. Szaflarski, & Michael A. Matthay. (1995). Frequency and importance of barotrauma in 100 patients with acute lung injury. Critical Care Medicine. 23(2). 272–278. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact